Pharmaceuticals Latin America

Latin America Precision Oncology Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

Latin America Precision Oncology Market Industry Trends and Forecast to 2034: Segmented by (Product, Cancer, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Latin America · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $5.44 Bn Placeholder estimate
Estimate 2025 $6.03 Bn 5.2% of the global market
Projected 2034 $15.17 Bn 151.7% Adds $9.14 Bn over 9 forecast years
CAGR 2025–2034 10.8% Faster than 59% of 180 Pharmaceuticals markets here
Key players 5
  • Latin America is 5.24% of the global market.
  • Among regions, the largest is North America at $59.45 Bn.
  • Fastest growing: Africa at 11.3% a year.
  • Latin America ranks 4th of 6 by size among regions.

Market size projection

Latin America

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$9.14 Bn total, 2026–2034

Year-by-year market size, 2024–2034
Precision Oncology Market market size by year, Latin America
YearMarket sizeChange that yearSince 2025
2024 (estimate) $5.44 Bn — —
2025 (base) $6.03 Bn +$587.5 Mn —
2026 (forecast) $6.68 Bn +$650.9 Mn +10.8%
2027 (forecast) $7.40 Bn +$721.2 Mn +22.8%
2028 (forecast) $8.20 Bn +$799.1 Mn +36%
2029 (forecast) $9.08 Bn +$885.4 Mn +50.7%
2030 (forecast) $10.06 Bn +$981.0 Mn +67%
2031 (forecast) $11.15 Bn +$1.09 Bn +85%
2032 (forecast) $12.36 Bn +$1.20 Bn +105%
2033 (forecast) $13.69 Bn +$1.33 Bn +127.2%
2034 (forecast) $15.17 Bn +$1.48 Bn +151.7%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Latin America Precision Oncology Market Analysis at a glance
Market size, 2025$6.03 Bn placeholder estimate
Forecast, 2034$15.17 Bn placeholder estimate
Growth (CAGR), 2025–203410.8% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, cancer and end user (see all)
Key playersRoche, Illumina, Inc., Tempus, Caris Life Sciences, Thermo Fisher Scientific Inc. (see all)
Active clinical trials2 in Latin AmericaSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Latin America. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Latin America Precision Oncology Market Analysis Executive Summary

Precision oncology matches cancer treatment to the genetic changes in a patient's tumour, using tests and targeted drugs.

Key segments of the precision Oncology market include product (Genomic Tests, Targeted Therapies and Informatics Platforms) and cancer (Lung, Breast and Colorectal).

Bar chart: Latin America Precision Oncology market size, 2024–2034, placeholder estimates. $5.44 Bn in 2024, $6.03 Bn in 2025 and $15.17 Bn in 2034, 10.8% CAGR.
Latin America Precision Oncology market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Latin America Precision Oncology Market Dynamics

Market Growth Drivers

Rising cancer cases, earlier detection, precision medicine and a strong pipeline of targeted and immune therapies are driving the precision Oncology market. Faster approvals and new combinations are improving survival.

Opportunity

Biomarker-led treatment, earlier lines of therapy and expansion into emerging markets offer strong growth for the precision Oncology market.

Market Restraints

High treatment costs, drug resistance, side effects and unequal access to cancer centres hold back the precision Oncology market, especially in low- and middle-income countries.

Competitive Landscape for Precision Oncology Market in Latin America

The precision Oncology market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Precision Oncology Market in Latin America

Precision Oncology in Latin America: rules, payment and research

In some of the countries we cover here, medicines are approved by ANVISA (Brazil)⁠[1], ARCSA (Ecuador)⁠[2] and COFEPRIS (Mexico)⁠[3]. How care is paid for in some of these countries: the SUS (Brazil)⁠[4]; public care and IESS (Ecuador)⁠[5]; and IMSS, ISSSTE and IMSS-Bienestar (Mexico)⁠[6]. ClinicalTrials.gov lists 2 studies on Precision Oncology that are recruiting, active or about to start in Latin America.⁠[7]

[1] ANVISA. Checked 14 Nov 2026.

[2] ARCSA. Checked 14 Nov 2026.

[3] COFEPRIS. Checked 14 Nov 2026.

[4] CONITEC. Checked 14 Nov 2026.

[5] Ministry of Public Health of Ecuador. Checked 14 Nov 2026.

[6] Mexican Social Security Institute (IMSS). Checked 14 Nov 2026.

[7] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Latin America. Retrieved 12 Nov 2026.

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for precision Oncology. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Latin America.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Precision Oncology right now, from free public sources.

Clinical trials

2 active trials in Brazil, Mexico, Ecuador and Haiti

Recruiting, about to start, or running now. Counted across the 4 countries we report on in Latin America.

Top trial sponsors (worldwide)

  1. Tempus 5 active trials on ClinicalTrials.gov (opens in a new tab)
  2. Orca Biosystems, Inc. 2 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

See every trial on ClinicalTrials.gov (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Precision Oncology in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Precision Oncology market in Latin America?
Placeholder estimate: about $6.03 Bn in 2025, rising to about $15.17 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Precision Oncology market in Latin America growing?
Placeholder estimate: about 10.8% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Precision Oncology market report cover?
The report splits the market by product (Genomic Tests, Targeted Therapies, Informatics Platforms), cancer (Lung, Breast, Colorectal, Blood Cancers) and end user (Hospitals, Specialty Clinics, Retail Pharmacies, Online Pharmacies).
Who are the key players in the Precision Oncology market?
Key players include Roche, Illumina, Inc., Tempus, Caris Life Sciences and Thermo Fisher Scientific Inc..
What is driving the Precision Oncology market?
Rising cancer cases, earlier detection, precision medicine and a strong pipeline of targeted and immune therapies are driving the precision Oncology market. Faster approvals and new combinations are improving survival.
How many clinical trials on Precision Oncology are running in Latin America?
2 studies are recruiting, active or about to start in Latin America, counted across the 4 countries we report on there, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Latin America. Retrieved 12 Nov 2026.
How much research is published on Precision Oncology?
PubMed lists 7,542 papers on Precision Oncology added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Pharmaceuticals reports in Latin America

See all

Related on oncology and genomics

See the topic